Lendacin 2 g

Quick links

Choose a section

Quick links to important sections

Advertisements

Lendacin 2 g

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Lendacin 2 g

Property Description
Active ingredient Ceftriaxone
Form Sterile powder for solution for injection
Pharmacological class Broad-spectrum antibiotic (Third-generation Cephalosporin)
General purpose To treat serious systemic bacterial infections
Origin Semi-synthetic

What Type of Medicine is Lendacin 2 g?

Lendacin 2 g is a semi-synthetic, single-ingredient medicinal product classified as a broad-spectrum antibiotic. Its sole active ingredient is Ceftriaxone, which positions it within the Third-generation Cephalosporin family of antimicrobials. This classification defines its utility for combating severe and systemic bacterial infections. As a prescription-only medicine, its efficacy against a wide range of bacterial pathogens is clinically recognized, further emphasizing its intended use, typically in hospital settings.

Composition, Origin, and Preparation Form

Lendacin 2 g is supplied as a sterile powder for solution for injection, with the "2 g" indicating the precise mass of the active compound, Ceftriaxone, contained in the vial. This powder, which is semi-synthetic in origin, must be reconstituted using a sterile vehicle, such as water for injection, immediately before use. The injectable form is used to achieve the high concentrations required for effective systemic treatment. This ensures rapid and complete distribution of the antibiotic throughout the patient's system via parenteral administration (intramuscular or intravenous).

How Does the Cephalosporin Class Work Against Bacteria?

The general purpose of Lendacin 2 g is to act as a bactericidal agent, meaning it actively kills the bacteria rather than merely inhibiting their growth. As a beta-lactam antibiotic, Ceftriaxone functions by interfering with the microbial process of building and maintaining its cell wall. This specific mechanism targets a structure unique to the bacterial organism, causing the infectious cells to disintegrate and thereby providing a powerful, systemic defense necessary for managing acute bacterial diseases.

Regulatory References

  1. NIH/NCBI Bookshelf on Ceftriaxone
Advertisements

What side effects are possible with Lendacin 2 g?

Possible side effects and safety information

Lendacin 2 g (Ceftriaxone) has an official safety profile structured by government regulatory documents, including the FDA and EMA, which classify adverse reactions by incidence and affected body system.

Frequency and System Classification

Adverse reactions are categorized based on their observed frequency. Common adverse reactions, defined as those occurring in 2% of patients in clinical trials, include gastrointestinal effects like diarrhea and changes in blood parameters such as eosinophilia, thrombocytosis, and leukopenia, alongside elevations of liver enzymes. Effects are grouped into System-Organ Classes, principally involving Gastrointestinal Disorders, Blood and Lymphatic System Disorders, and Hepatobiliary Disorders.


Serious Adverse Reactions and Safety Constraints

Regulatory warnings highlight potential for clinically significant events. These Serious Adverse Reactions include immediate, life-threatening allergic responses like Anaphylaxis, severe forms of Hemolytic Anemia, and the risk of Clostridium difficile-associated diarrhea, which can range in severity. Post-marketing surveillance also notes the potential for Serious Neurological Adverse Reactions such as encephalopathy and convulsions.

Specific Safety Constraints are mandatory. The medicine is contraindicated in hyperbilirubinaemic (jaundiced) and preterm newborns due to the risk of bilirubin encephalopathy. Furthermore, it must not be administered simultaneously with any calcium-containing intravenous solutions due to the documented risk of forming Ceftriaxone-calcium salt precipitates.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents define the manifestations of Lendacin 2 g (Ceftriaxone) overexposure and the mandatory emergency response actions.

Documented Manifestations and Severe Outcomes

Overdosage may present with documented gastrointestinal disturbances, specifically nausea, vomiting, and diarrhoea. Of greater concern, high systemic concentrations of the compound are officially associated with a risk of serious neurological adverse reactions. These manifestations, which include convulsions, myoclonus, and altered mental state, require immediate attention. Official labels indicate that patients with severe renal impairment are at an increased risk of toxicity, underlining the need for appropriate management.

Mandated Emergency Action

If any serious neurological adverse reactions occur, regulatory guidance requires the drug to be discontinued and appropriate supportive measures instituted. Treatment for overdosage is symptomatic, as the official information states no specific antidote is known. Furthermore, it is officially documented that Ceftriaxone concentrations cannot be reduced by procedures such as haemodialysis or peritoneal dialysis. Urgent medical help must be sought whenever severe neurological signs are present.

Advertisements

Therapeutic Uses of Lendacin 2 g

What Lendacin 2 g Treats: Main Uses and Benefits

Lendacin 2 g (Ceftriaxone) is commonly used to help manage symptoms associated with serious, systemic bacterial infections. Its use is relevant in conditions presenting with acute or disruptive episodes, contributing to support and comfort and may assist with managing symptoms associated with severe illness. This medication is commonly used for managing symptoms associated with critical infections affecting the entire body, such as sepsis, bacterial meningitis, and severe organ infections like pneumonia, complicated urinary tract infections, and bone and joint infections.

“This type of supportive symptomatic coverage is relevant when symptoms become temporarily overwhelming and require short-term assistance.”

The medication is applied in clinical settings that involve acute or unstable symptom patterns, helping address symptom clusters that may become intense or disruptive, such as high fever, systemic imbalance, and localized pain in deep tissues. The use of this antibiotic assists with maintaining functional stability by supporting the management of symptoms linked to bacterial invasion, particularly in high-risk scenarios like surgical prophylaxis and empiric treatment for fever in immunocompromised patients.


Quick Fact: Relief for Systemic Imbalance

Lendacin 2 g is commonly used to help manage symptoms related to systemic imbalance and heightened physiological activity associated with acute or disruptive episodes.

Advertisements

Eligibility and Restrictions for Use

Lendacin 2 g (Ceftriaxone) is an injectable medicine whose use is strictly defined by regulatory eligibility criteria, primarily based on the risk of severe reactions or harmful precipitation.

Populations Who Must Not Use Lendacin 2 g (Contraindications)

  • Hypersensitivity: Patients with a known allergy to Ceftriaxone, any other cephalosporin drug, or a history of severe allergic reaction (e.g., anaphylaxis) to penicillin or other beta-lactam antibiotics.
  • Neonates and Calcium Products: The medicine is strictly contraindicated in neonates (up to 28 days of age) if they require, or are expected to require, treatment with calcium-containing intravenous (IV) solutions. This includes continuous infusions like parenteral nutrition, due to the risk of life-threatening ceftriaxone-calcium precipitation.
  • Hyperbilirubinemic Neonates: Use is contraindicated in hyperbilirubinemic (jaundiced) neonates, especially premature infants, due to the theoretical risk of bilirubin encephalopathy.
  • Concurrent IV Administration: Lendacin must not be administered simultaneously with calcium-containing IV solutions in any patient, regardless of age, even via separate infusion lines (Y-site administration).

Restricted Use and Special Considerations

  • Sequential Administration: In patients older than 28 days, Lendacin and calcium-containing solutions may be given sequentially, but the IV lines must be thoroughly flushed with a compatible fluid between administrations.
  • Organ Impairment: Patients with combined severe renal and hepatic dysfunction should not receive more than 2 grams of ceftriaxone per day, as noted in the prescribing information.
Advertisements

What should I know about interactions with other medicines?

The interaction profile of Lendacin 2 g (Ceftriaxone) is structured around high-risk physical and pharmacodynamic incompatibilities documented by regulatory authorities.

The most critical interaction concerns calcium-containing IV solutions (e.g., Ringer's Solution, Lactated Ringer's). Co-administration of Ceftriaxone and these solutions is contraindicated in neonates (le 28 days) due to the documented risk of potentially fatal ceftriaxone-calcium salt precipitation. For all patient age groups, simultaneous administration through a Y-site is strictly prohibited as a procedural restriction. Patients older than 28 days may receive the products sequentially, provided the intravenous lines are thoroughly flushed with a compatible fluid between administrations.

A further documented interaction involves Vitamin K Antagonists (VKAs), such as Warfarin. Co-administration can officially lead to alterations in Prothrombin Time, which is associated with an increased risk of bleeding. Regulatory labels note that patients with impaired Vitamin K synthesis, such as those with chronic hepatic disease, may require specific monitoring for this effect. Additionally, the label notes potential pharmacodynamic interactions: co-administration with Aminoglycoside antibacterials carries a documented potential for an additive increase in the risk of nephrotoxicity, and antagonistic effects have been observed in vitro with Chloramphenicol. No specific interactions with food, alcohol, or herbal products are explicitly documented in the cited regulatory sources.

Advertisements

Mechanism of Action

Lendacin 2 g is a cephalosporin antibiotic that exerts its effect primarily by targeting structures essential for bacterial survival and replication. This mechanism leads to the disruption of key processes in the bacterial cell, resulting in its destruction.


Inhibition of Bacterial Cell Wall Synthesis

This mechanism involves the drug's direct covalent binding and inhibitory molecular interaction with penicillin-binding proteins (PBPs), which are transpeptidase enzymes crucial for the cell wall's assembly. By occupying the active site of these targets, Lendacin 2 g modifies the final molecular steps of cell wall construction. The immediate consequence is the failure to properly cross-link and synthesize the peptidoglycan layer, which is necessary for the structural integrity and rigidity of the bacterial cell.


Induction of Lysis and Cell Death

The defect in cell wall synthesis initiates a downstream mechanistic cascade. The structural deficiency triggers the continuous and unchecked activity of endogenous bacterial autolytic enzymes (autolysins). These enzymes effectively degrade the defective cell wall structure. This process results in predictable physiological adjustments, as the bacterium can no longer withstand internal osmotic pressure, leading to membrane rupture, cell lysis, and the resulting bactericidal effect.

Advertisements

Dosage and Administration Information

How to Use Lendacin 2 g: Official Administration Guidelines

Lendacin 2 g is a sterile powder that must be reconstituted before administration, which is done through a parenteral route. The administration is governed by specific instructions regarding dose, frequency, and preparation.


Administration Scope

Feature Official Instruction
Route of Administration Intravenous (IV) injection/infusion or Intramuscular (IM) injection.
Dosing Schedule (Adults) Usual Daily Dose: 1 g to 2 g daily. Maximum Dose: Generally should not exceed 4 g per day. Surgical Prophylaxis: Single 1 g IV dose.
Frequency Pattern Once daily (every 24 hours), or in equally divided doses twice a day (every 12 hours) when higher doses are required.
Course Duration Typically 4 to 14 days, continuing for at least 48 to 72 hours after the patient is afebrile.

Key Procedural Requirements

  • Preparation: The sterile powder must be reconstituted with an appropriate sterile diluent, such as water for injection or sodium chloride 0.9%, immediately before use. The resulting solution is for parenteral administration.
  • IV Infusion Time: For most adult and pediatric patients, IV administration is typically given by slow infusion over at least 30 minutes.
  • IM Injection Rules: Doses greater than 1 g for IM injection must be divided and administered into multiple large muscle sites.
  • Calcium Constraint: Lendacin 2 g must not be mixed or administered simultaneously with any calcium-containing IV solutions or products, even via different infusion lines.
  • Population Adjustments: For patients with both severe renal and hepatic dysfunction, the total daily dose should not exceed 2 g per day.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evaluating the Drug's Performance and Use

Research was designed to study the drug's performance in relation to Component A and Component B. Studies have explored whether this combination impacts chronic inflammation. The primary studies examined its use in individuals with severe rheumatoid arthritis (RA) and psoriatic arthritis (PsA).

Efficacy Findings

Multiple studies have been conducted to evaluate whether the combination therapy is associated with changes in patient outcomes.

Studies assessed whether the drug was associated with changes in key biomarkers of inflammation, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Some research compared the outcomes of the combination to those of monotherapy. One goal of the research was to evaluate whether a faster rate of clinical remission was observed.

Phase 3 trials assessed the treatment's primary efficacy endpoints. Overall, research has explored whether the observed changes were related to clinical benefits, such as a reduction in tender and swollen joint counts.

Adverse Event Reporting

The majority of studies assessed the incidence of adverse events and tolerability of the treatment over a long period. Data on individuals with pre-existing mild liver conditions was also evaluated, but evidence remains limited. Common adverse events observed in the trials included:

  • Headache
  • Gastrointestinal distress
  • Injection site reactions

A smaller number of studies explored specific cardiovascular effects. Research assessed whether the treatment was associated with changes in blood pressure in individuals with uncontrolled hypertension. Furthermore, studies have explored the drug's potential association with changes in liver enzyme levels over time.

Key Studies & References

  1. Therapeutic Advancements in Psoriasis and Psoriatic Arthritis - MDPI
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Lendacin 2 g (FAQ)

Q: What is Lendacin 2 g specifically used to treat?

A: Lendacin 2 g is indicated for the treatment of specific, often serious, bacterial infections. Official prescribing information states its use in conditions like lower respiratory tract infections, skin and skin structure infections, and certain forms of meningitis.

Q: What other medicines are known to interact with Lendacin 2 g?

A: Regulatory warnings emphasize that calcium-containing IV solutions must not be administered simultaneously, as this is strictly prohibited. Documented interactions also exist with blood thinners, such as Vitamin K antagonists, which can alter clotting time. Official information notes a potential for increased kidney risk when used with Aminoglycoside antibiotics.

Q: What kind of research or clinical evidence supports the use of Lendacin 2 g?

A: The use of Lendacin 2 g is supported by clinical studies and controlled trials that have examined its performance in its approved indications. Regulatory documents describe its mechanism as a bactericidal agent, meaning it acts by killing bacteria. Official documents provide detailed summaries of these clinical findings.

Q: Does Lendacin 2 g affect liver function or require monitoring?

A: Elevations of liver enzymes have been documented as an adverse reaction. Furthermore, official prescribing information notes that patients with combined severe renal (kidney) and hepatic (liver) dysfunction may require specific dose adjustments. The need for monitoring is determined by the healthcare provider during clinical management.

Q: Can patients with pre-existing kidney issues use Lendacin 2 g?

A: Official prescribing information addresses use in patients with organ impairment. Individuals with significant renal (kidney) impairment or combined severe kidney and liver dysfunction may require adjustments to the administered dose, as detailed in regulatory documents.

Q: Is Lendacin 2 g ever used to treat children or adolescents?

A: Yes, official documentation indicates that Lendacin 2 g is approved for use in specific pediatric and adolescent age groups, with specific dosing recommendations for these patients. However, the medicine is contraindicated in hyperbilirubinemic (jaundiced) neonates (newborns).

Q: What information is available regarding the long-term safety of Lendacin 2 g?

A: The long-term safety of Lendacin 2 g is evaluated through data collected from controlled clinical studies and continuous post-marketing surveillance. This process provides official information regarding the incidence and severity of reported adverse events over a long period.

Q: Does Lendacin 2 g affect the results of routine blood tests?

A: Lendacin 2 g is documented to affect certain laboratory parameters. Changes in routine blood tests, such as eosinophilia, thrombocytosis, and leukopenia, are noted as adverse reactions associated with the use of the medicine.

Q: Can Lendacin 2 g be used by people with a history of penicillin allergy?

A: Official documents state that Lendacin 2 g is contraindicated if a patient has a known allergy to any cephalosporin or a history of a severe allergic reaction (like anaphylaxis) to any beta-lactam drug, which includes penicillin.

Q: Is it safe to drink alcohol while receiving treatment with Lendacin 2 g?

A: Regulatory documents state that no specific drug interaction between Lendacin 2 g and alcohol has been officially documented.

Q: Is Lendacin 2 g suitable for older adults or elderly patients?

A: Official prescribing information regarding geriatric use indicates that no overall differences in efficacy or safety were observed between older and younger adult patients. However, greater sensitivity of some older individuals cannot be ruled out, which is a standard regulatory consideration.

Q: Is Lendacin 2 g usually administered in a hospital setting?

A: Lendacin 2 g is administered intravenously (IV) or intramuscularly (IM), requiring sterile reconstitution and controlled infusion times. Due to these procedural requirements, the administration typically occurs under the direct supervision of a healthcare professional in a clinical setting, such as a hospital or clinic.

Q: Can Lendacin 2 g cause changes in mood, like anxiety or depression?

A: While serious neurological adverse reactions, such as encephalopathy and convulsions, have been reported in official warnings, specific changes in mood like anxiety or depression are not listed among the frequently reported side effects.

Q: Does Lendacin 2 g interact with common over-the-counter pain relievers?

A: According to official documents, no specific interaction is documented between Lendacin 2 g and common over-the-counter pain relievers.

Q: What are the official rules for using Lendacin 2 g during pregnancy?

A: Official prescribing information indicates that Lendacin 2 g is generally described as being used during pregnancy only if the potential benefits are considered to justify the potential risks to the developing fetus.

Q: Are there specific food or beverage restrictions when using Lendacin 2 g?

A: Regulatory documents state that no specific drug interaction has been officially documented between Lendacin 2 g and food or beverages.

Q: Does Lendacin 2 g cause dizziness or affect a person's ability to drive?

A: Dizziness is not listed as a common side effect in official documents. However, the medicine has warnings regarding the potential for serious neurological adverse reactions, which may affect a person's ability to perform complex tasks.

Q: Are there known interactions between Lendacin 2 g and birth control pills?

A: Official documents state that no specific interaction is documented between Lendacin 2 g and oral contraceptive products (birth control pills).

Q: Can Lendacin 2 g cause skin rashes or hives?

A: Yes, official documentation reports that skin reactions, including rash, are documented as an adverse reaction associated with the use of Lendacin 2 g.

Q: What should a patient do if they experience severe side effects from Lendacin 2 g?

A: Severe side effects, particularly life-threatening allergic responses such as anaphylaxis, are listed in official warnings as requiring the immediate discontinuation of the medicine. Regulatory documents stress that prompt medical intervention is required in such instances.

Q: Can a patient develop resistance to Lendacin 2 g?

A: As with other antibiotics in the cephalosporin class, the development of bacterial resistance to Lendacin 2 g is possible. Official microbiology information indicates that resistance has been documented.

Q: Are there different forms of Lendacin 2 g available besides the 2 g version?

A: Official prescribing information confirms that Lendacin is supplied in multiple strengths, not just the 2 g version. All available forms and strengths are detailed in the product's official 'How Supplied' section.

Q: Does Lendacin 2 g interact with commonly used nutritional supplements?

A: According to official regulatory documents, no specific interaction is documented between Lendacin 2 g and commonly used nutritional supplements.

Q: What happens in the body to Lendacin 2 g after it is administered?

A: The pharmacological data section of the official documents details the medicine's pharmacokinetics, which describes what happens to Lendacin 2 g in the body. This includes information on its absorption, how it is distributed to tissues, its metabolism, and how it is eliminated from the body.

Q: What kind of organisms is Lendacin 2 g effective against?

A: Official microbiology information indicates that Lendacin 2 g has been shown to be effective against specific susceptible strains of both gram-negative and gram-positive organisms. The spectrum of activity is detailed in the official documents.

Q: Does Lendacin 2 g have any potential for misuse or dependency?

A: Official documents include a section on drug abuse and dependence. For Lendacin 2 g, regulatory information states that there are no documented reports of drug dependence or potential for misuse/abuse.

Q: Is Lendacin 2 g suitable for use while breastfeeding?

A: Low concentrations of the active ingredient are known to be excreted in human milk. Official documents recommend that the decision regarding use during lactation should involve considering the benefits of breastfeeding versus the potential risks to the breastfed infant.

Q: How long after stopping Lendacin 2 g does the drug stay in the body?

A: The rate at which the active ingredient is eliminated from the body is generally represented by its half-life. This specific information is detailed in the pharmacokinetic data section of the official documents.

Advertisements

How should Lendacin 2 g be stored and disposed of?

How to Store and Dispose of Lendacin 2 g?

The storage and disposal requirements for Lendacin 2 g (Ceftriaxone powder for injection) are strictly defined by regulatory authorities to maintain product stability and ensure safety.


Storage Requirements

Condition Requirement (Unreconstituted Powder)
Temperature Store at Controlled Room Temperature, between 20 C and 25 C (68 F to 77 F).
Protection Must be protected from light. Keep the container tightly closed.
Child Safety Must be stored out of the sight and reach of children and in a locked up location.

Prepared Solution Stability

Once reconstituted, the solution has a defined stability period. It can be stored under refrigeration (2 C to 8 C) and must be used within 48 hours. The solution should not be refrozen after thawing.

Disposal

All unused or expired product and waste materials must be disposed of in accordance with local requirements. Instructions include disposing of contents and containers at an approved waste disposal plant and taking care to prevent entry into waterways.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lendacin 2 g found in:

A-Z Index: